The LEAD Coalition and ResearchersAgainstAlzheimer’s invite you to participate in our conference call on February 7th at 3pm Eastern: “Accelerating Alzheimer’s Research & Drug Discovery Through a National Institutional Review Board for Neurodegenerative Diseases.”

NOTE: Registration is now closed.

An audio recording of the conference call will be posted on the LEAD website later this month.

Ara Khachaturian, PhD, from Prevent Alzheimer’s Disease 2020 will discuss the development process for a National Institutional Review Board, challenges ahead, and how a well-designed, highly-qualified, and responsive National Institutional Review Board promises to provide better safeguards for clinical trial participants while more efficiently accelerating the scientific enterprise to bend the curve of Alzheimer’s disease.